Back to Search
Start Over
SWITCH TO DOR/ISL (100/0.75MG) QD FROM B/F/TAF: WEEK 48 RESULTS FROM A PHASE 3 TRIAL.
- Source :
- Topics in Antiviral Medicine; Apr2023, Vol. 31 Issue 2, p81-81, 1/2p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 21615861
- Volume :
- 31
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Topics in Antiviral Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 163303450